Cellular immune function and liver damage in post-hepatitic cirrhosis

Table 1 Immune function assay in post-hepatitic cirrhosis patients (¯x ± s)

Assays	PHC (n)b	Control (n)
LT test (SI)	18.1 ± 13.0 (48)	34.9 ± 21.7 (22)
IL-2 activity (SI)	8.1 ± 6.0 (41)	13.6 ± 5.8 (20)
NK activity (%)	40.3 ± 21.7 (49)	61.2 ± 20.5 (22)
IgG (g/L)	17.9 ± 7.7 (29)	10.0 ± 5.1 (22)
IgA (g/L)	3.2 ± 2.4 (29)	1.6 ± 0.8 (22)
IgM (g/L)	1.4 ± 0.8 (29)	0.8 ± 0.2 (22)
Complement C3 (g/L)	0.5 ± 0.2 (29)	1 ± 0.6 (22)

Table 2 Cellular immune function in post-hepatitic cirrhosis patients and Child-Pugh classification (¯x ± s)

Assays	Child-Pugh class
	A (n)	B (n)	C (n)
LT test (SI)	20.9 ± 16.7 (17)	19.9 ± 11.1 (18)	10.1 ± 5.4 (13)a
IL-2 activity (SI)	10.7 ± 7.9 (16)	7.4 ± 3.4 (13)a	5.2 ± 3.3 (12)b
NK activity (%)	46.5 ± 19.9 (18)	38.5 ± 15.4 (18)a	19.5 ± 11.3 (13)b